MediWound Ltd. (MDWD) Dividend History

Company News

• MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

  MediWound has initiated a global Phase III trial to evaluate the efficacy and safety of its wound debridement therapy EscharEx for the treatment of venous leg ulcers. The trial aims to assess EscharEx's ability to effectively debride chronic wounds and prepare the wound bed for healing.

  GlobeNewswire Inc.

  Featured Companies: MDXG SOLV
• MediWound shares hold Buy rating from TD Cowen on significant grant - Investing.com

  MediWound Ltd. has received a €16.25 million grant from the European Innovation Council, which is expected to accelerate the development of its product EscharEx for Diabetic Foot Ulcers. TD Cowen has maintained a Buy rating on MediWound's stock with a $25.00 price target.

  Investing.com
• MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program - GlobeNewswire

  MediWound Ltd. has been awarded €16.25 million in funding from the European Innovation Council to accelerate the development of its EscharEx® product for treating diabetic foot ulcers, which could significantly impact the lives of millions of patients.

  GlobeNewswire Inc.
• MediWound Announces $25 Million Strategic Private Placement Financing - GlobeNewswire

  Mölnlycke Health Care, a global leader in wound care solutions, has invested $15 million in MediWound, a company developing next-generation enzymatic therapeutics for tissue repair. The investment will support MediWound's pre-commercial activities and development of manufacturing capabilities for its lead drug, EscharEx.

  GlobeNewswire Inc.
• Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Sharps ... - Benzinga

  Sharps Technology shares jumped 31.7% in pre-market trading after the company announced it received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery. Several other stocks also saw significant pre-market movements.

  Benzinga

  Featured Companies: ACHR APLD BTDR GP GREE GREEL IREN KOSS MAXN QLGN STSS WULF